Symposium

COVID-19

Clinical Practice (assessment, diagnosis, treatment, knowledge translation/EBP, implementation science, program development)

Meeting the Needs of Individuals with Cognitive Dysfunction after COVID-19: Neuropsychological Profiles, Assessment, and Treatment

Friday, November 11, 2022

1:00 PM – 2:15 PM

Presenter(s)

Abhishek Jaywant, PhD

Assistant Professor of Neuropsychology
Weill Cornell Medicine, United States
Chelsea J. Steinberg, OTR/L, C/NDT

Assistant Unit Supervisor of Inpatient Rehabilitation Occupational Therapy
NYU Langone Health/Rusk Rehabilitation
New York, New York, United States
Joan Toglia, PhD, OTR/L, FAOTA

Adjunct Clinical Professor, Rehabilitation Medicine
New York Presbyterian/ Weill Cornell Medical College
Hastings On Hudson, New York, United States

Slides

COVID-19 is associated with deficits in processing speed and executive functions, as well as increased cognitive fatigue. Emerging evidence suggests that these deficits are associated with disruption to specific neural networks and are associated with poor functional outcomes. Neuropsychological and functional assessment at the impairment, activity, and participation levels, are critical in developing an individualized treatment plan. Specific neuropsychological, functional, and patient-reported measures may be especially well-suited to capturing post-COVID cognitive dysfunction. Metacognitive strategy intervention can be applied to post-COVID cognitive dysfunction to promote awareness, monitoring, perceived control, and management of cognitive symptoms. The presenters will review the latest research on post-COVID-19 cognitive sequelae, discuss specific assessment tools, and describe the use of a metacognitive strategy intervention (the multicontext approach) in a case presentation of an individual with persistent cognitive dysfunction after COVID-19.

Learning Objectives:

Describe the neuropsychological deficits, associated neuroanatomical disruption, and functional outcomes after COVID-19
Identify neuropsychological tests, functional cognitive assessment measures, and patient-reported outcome measures that are useful in assessing post-COVID-19 cognitive dysfunction.
List and explain treatment strategies and methods that can be used to optimize everyday functioning in COVID-19 survivors with mild cognitive dysfunction.
Describe the use of the Multicontext Approach in treating cognitive dysfunction after COVID-19